Back to search

United Kingdom· GB-APID-23825911000001105

Co-amilofruse 2.5mg/20mg tablets

A medicinal product containing co-amilofruse, registered in United Kingdom by DE Pharmaceuticals.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCo-amilofruse 2.5mg/20mg tabletsATC—REGISTER NO.GB-APID-2382591100000…PACKS LISTED0CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Co-amilofruse
Manufacturer
DE Pharmaceuticals
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c3ed453f-738d-430a-bc0f-caa67e76281f
GET /v1/drugs/c3ed453f-738d-430a-bc0f-caa67e76281f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "23825911000001105",
  "desc": "Co-amilofruse 2.5mg/20mg tablets (DE Pharmaceuticals)",
  "form": "Oral tablet",
  "vpid": "42293311000001101",
  "source": "dmd",
  "vtm_id": "34186711000001102",
  "strength": "2.5 mg",
  "substance": "Co-amilofruse",
  "ingredient": "Amiloride hydrochloride",
  "supplier_code": "2268901000001109"
}

See everything about co-amilofruse.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.